BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37432630)

  • 1. Novel Medical Therapies in Meningiomas.
    Danish H; Brastianos P
    Adv Exp Med Biol; 2023; 1416():213-223. PubMed ID: 37432630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapies for meningiomas.
    Wen PY; Drappatz J
    Expert Rev Neurother; 2006 Oct; 6(10):1447-64. PubMed ID: 17078786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted drug therapy for meningiomas.
    Norden AD; Drappatz J; Wen PY
    Neurosurg Focus; 2007; 23(4):E12. PubMed ID: 17961036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical management of meningiomas.
    Chukwueke UN; Wen PY
    Handb Clin Neurol; 2020; 170():291-302. PubMed ID: 32586501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons.
    Karsy M; Guan J; Cohen A; Colman H; Jensen RL
    Neurosurg Clin N Am; 2016 Apr; 27(2):249-60. PubMed ID: 27012389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of recurrent meningiomas.
    Chamberlain MC; Barnholtz-Sloan JS
    Expert Rev Neurother; 2011 Oct; 11(10):1425-32. PubMed ID: 21955199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy and targeted therapies for meningiomas: what is the evidence?
    Graillon T; Tabouret E; Chinot O
    Curr Opin Neurol; 2021 Dec; 34(6):857-867. PubMed ID: 34629433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in meningioma genetics: novel therapeutic opportunities.
    Preusser M; Brastianos PK; Mawrin C
    Nat Rev Neurol; 2018 Feb; 14(2):106-115. PubMed ID: 29302064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Biomarkers of Meningioma: A Focused Review.
    Pawloski JA; Fadel HA; Huang YW; Lee IY
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy: What is its role in meningioma?
    Sherman WJ; Raizer JJ
    Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma.
    Chamberlain MC
    Curr Opin Oncol; 2012 Nov; 24(6):666-71. PubMed ID: 22759739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical therapies for meningiomas.
    Wen PY; Quant E; Drappatz J; Beroukhim R; Norden AD
    J Neurooncol; 2010 Sep; 99(3):365-78. PubMed ID: 20820875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningioma genomics: a therapeutic challenge for clinicians.
    Moussalem C; Massaad E; Minassian GB; Ftouni L; Bsat S; Houshiemy MNE; Alomari S; Sarieddine R; Kobeissy F; Omeis I
    J Integr Neurosci; 2021 Jun; 20(2):463-469. PubMed ID: 34258948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bevacizumab in refractory higher-grade and atypical meningioma: the current state of affairs.
    Dasanu CA; Alvarez-Argote J; Limonadi FM; Codreanu I
    Expert Opin Biol Ther; 2019 Feb; 19(2):99-104. PubMed ID: 30556741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and meningioma DNA synthesis.
    Johnson MD; O'Connell MJ; Walter K
    BMC Complement Altern Med; 2013 Nov; 13():303. PubMed ID: 24188277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-grade meningiomas: new avenues for drug treatment?
    Preusser M; Berghoff AS; Hottinger AF
    Curr Opin Neurol; 2013 Dec; 26(6):708-15. PubMed ID: 24184974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the systemic therapy for recurrent meningiomas and the challenges ahead.
    Li Y; Drappatz J
    Expert Rev Neurother; 2023; 23(11):995-1004. PubMed ID: 37695700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapies in meningioma-where are we?
    Miyagishima DF; Moliterno J; Claus E; Günel M
    J Neurooncol; 2023 Jan; 161(2):297-308. PubMed ID: 36418843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New molecular targets in meningiomas: the present and the future.
    Venur VA; Santagata S; Galanis E; Brastianos PK
    Curr Opin Neurol; 2018 Dec; 31(6):740-746. PubMed ID: 30379704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
    Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I
    Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.